Get a free sample of Ovarian Cancer Diagnostic Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Ovarian Cancer Diagnostic Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Ovarian Cancer Diagnostic Market Size
Ovarian Cancer Diagnostic Market size was valued at around USD 1.54 billion in 2023 and is anticipated to register a CAGR of 6.6% between 2024 and 2032. Ovarian cancer diagnostic refers to the process of identifying and determining the presence of ovarian cancer in individuals suspected of having the disease. Ovarian cancer diagnostic procedures encompass a range of tests, examinations, and imaging techniques aimed at detecting the presence of cancerous cells or tumors in the ovaries or surrounding tissues.
The increasing incidence and prevalence of ovarian cancer worldwide have heightened the demand for effective diagnostic methods. For instance, in 2024, the American Cancer Society projects that approximately 19,680 new cases of ovarian cancer will be diagnosed among women in the U.S., while roughly 12,740 women are expected to succumb to the disease.
Furthermore, ongoing research and development efforts in the field of oncology which is estimated to reach USD 690 billion by 2032, including ovarian cancer have led to the discovery of novel biomarkers, imaging techniques, and diagnostic technologies. This continuous innovation enhances the accuracy, sensitivity, and specificity of cancer diagnostics, enabling earlier detection of ovarian cancer and better patient outcomes.
Why is the demand for instruments/analyzers for ovarian cancer diagnosis expanding?
Instruments/analyzers segment garnered USD 965.7 million in 2023 and is set to gain traction by 2032, driven by technological advancements and growing awareness about the importance of early detection and screening for ovarian cancer.
How big is the ovarian cancer diagnostic market?
Global ovarian cancer diagnostic industry was valued at around USD 1.54 billion in 2023 and is estimated to reach over USD 2.71 billion by 2032, driven by increasing incidences of ovarian cancer worldwide.
Which companies define the competitive landscape of global ovarian cancer diagnostic industry?
Abbott Laboratories, Agilent Technologies, Canon Medical Systems Corporation, Danaher Corporation, F. Hoffmann-La Roche Ltd., Fujirebio Diagnostics, GE HealthCare Technologies Inc., Illumina Inc., Myriad Genetics, Philips Healthcare, Positron Corporation are some of the major industry contenders.
What factors are pushing the growth of North America ovarian cancer diagnostic market?
North America ovarian cancer diagnostic industry accounted for USD 624.4 million in 2023 and is predicted to witness substantial growth through 2032, driven by an advanced healthcare infrastructure and high levels of awareness regarding the importance of early cancer detection.